|
0
|
|
A randomized controlled Phase I de-escalation trial of molnupiravir and nirmatrelvir/ritonavir combination for mild-moderate SARS-CoV-2 infection.
(academic.oup.com)
|
Khoo SH
…
Griffiths G
Journal of Antimicrobial Chemotherapy
2026-06-03
|
#pharmacokinetics
#covid-19
#clinical trial
#antiviral
#safety
|
|
0
|
|
Alternative splicing broadens antiviral diversity at the human OAS2 locus.
(link.springer.com)
|
Davies EL
…
Fletcher AJ
The EMBO Journal
2026-06-03
|
#infection
#immunity
#splicing
#antiviral
#interferon
|
|
0
|
|
Synergistic antiviral effects of structure-guided peptides and a mutagenic base analog on SARS-CoV-2 replication.
(journals.asm.org)
|
Ortega Del Campo S
…
Grande Perez A
Antimicrobial Agents and Chemotherapy
2026-06-03
|
#covid-19
#sequencing
#antiviral
#mutagenesis
#peptide
|
|
0
|
|
Identification and characterization of a SARS-CoV-2 M(pro) G23 deletion ensitrelvir-resistant mutant.
(journals.asm.org)
|
Ma Y
…
Martinez-Sobrido L
mBio
2026-06-03
|
#amr
#mutation
#antiviral
#protease
|